Asian shrimp production and the economic costs of disease

Griffiths D., . and Pratoomyot J., . and Vu N. T., . and Jiravanichpaisal P., . and Shinn A. P., . and Briggs M., . and Trong T. Q., . Asian shrimp production and the economic costs of disease. pp. 29-58. ISSN 0116-6514

Using FAO aquaculture production statistics the global production of cultured crustaceans for 2018 is predicted to be 8.63 million tonnes. The growth of the shrimp industry however is impacted by episodes of disease resulting in huge national income losses (despite compensatory price rises in response to supply shortage) amounting to billions of dollars annually. To illustrate this the current study reviews losses over the past 40 years and then focuses on current disease problems in Asia notably AHPND (acute hepatopancreatic necrosis disease caused by pathogenic isolates of Vibrio parahaemolyticus) the microsporidian Enterocytozoon hepatopenaei (EHP) and WSSV (white-spot syndrome virus). The impacts of AHPND in affected countries with particular focus on Thailand and the changes in the number of farm operators land use and production is investigated. The economic loss from decreased production is followed through the volume of product traded through Mahachai Market one of Thailand's principal seafood markets throughout 2010“2017 and is estimated to be US 7.38 billion with a further US 4.2 billion in export losses. Shrimp disease-related losses within the Vietnamese Mekong Delta were in the absence of detailed production data estimated using an assumption-based exercise. Losses due to AHPND in 2015 were determined to be US 26 million while the costs of WSSV in the same year were US 11 million.

Full text available from: Official URL: http://www.asianfisheriessociety.org/publication/d...

Abstract

Using FAO aquaculture production statistics the global production of cultured crustaceans for 2018 is predicted to be 8.63 million tonnes. The growth of the shrimp industry however is impacted by episodes of disease resulting in huge national income losses (despite compensatory price rises in response to supply shortage) amounting to billions of dollars annually. To illustrate this the current study reviews losses over the past 40 years and then focuses on current disease problems in Asia notably AHPND (acute hepatopancreatic necrosis disease caused by pathogenic isolates of Vibrio parahaemolyticus) the microsporidian Enterocytozoon hepatopenaei (EHP) and WSSV (white-spot syndrome virus). The impacts of AHPND in affected countries with particular focus on Thailand and the changes in the number of farm operators land use and production is investigated. The economic loss from decreased production is followed through the volume of product traded through Mahachai Market one of Thailand's principal seafood markets throughout 2010“2017 and is estimated to be US 7.38 billion with a further US 4.2 billion in export losses. Shrimp disease-related losses within the Vietnamese Mekong Delta were in the absence of detailed production data estimated using an assumption-based exercise. Losses due to AHPND in 2015 were determined to be US 26 million while the costs of WSSV in the same year were US 11 million.

[error in script]

Item Type:	Article
AGROVOC Term:	Prawns and shrimps
AGROVOC Term:	Penaeus vannamei
AGROVOC Term:	Aquaculture
AGROVOC Term:	Fish production
AGROVOC Term:	Fish diseases
AGROVOC Term:	Vibrio parahaemolyticus
AGROVOC Term:	Animal viruses
AGROVOC Term:	Pathogens
AGROVOC Term:	Economic losses
AGROVOC Term:	Production costs
Depositing User:	Mr. AFANDI ABDUL MALEK
Last Modified:	24 Apr 2025 00:54
URI:	http://webagris.upm.edu.my/id/eprint/7973

Actions (login required)

View Item